Transporting newborn infants with suspected duct dependent congenital heart disease on low-dose prostaglandin E1 without routine mechanical ventilation

Browning Carmo, Kathryn A.; Barr, Peter; West, Maureen; Hopper, Neil W.; White, Jennifer P.; Badawi, Nadia
March 2007
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Mar2007, Vol. 92 Issue 2, pF117
Academic Journal
Aim: To evaluate the safety of transporting newborn infants with suspected duct dependent congenital heart disease (CHD) treated with prostaglandin E1 (PGE1) without routine mechanical ventilation. Methods: A retrospective population-based audit of newborn infants with suspected CHD transported on PGE1 by the New South Wales newborn and paediatric Transport Service from 1995 through 2005. Results: Mechanical ventilation was not used prior to treatment with PGE1 in 94 (3 1%) of the 300 infants. The indications for mechanical ventilation in the remaining 206 infants (69%) included elective mechanical ventilation because of the intention to use PGE1 (n = 125) and severe hypoxaemia, acidosis or cardiorespiratory failure prior to commencing PGE1 (n = 81). 16 (17%) of the 94 infants who were not ventilated initially required mechanical ventilation before transport because of apnoea, which developed within one hour of commencing PGE1. 2 (2.6%) of the 78 infants transported without mechanical ventilation developed apnoea in transit and both were receiving ⩾15 ng/kg/min of PGE1. Apnoea was more likely to occur in non-ventilated infants when the PGE1 infusion rate was ⩾15 ng/kg/min compared with <15 ng/kg/mm (14/33 vs 4/61, x² = 15.55, p<.001). Conclusions: Newborn infants with suspected duct dependent CHD treated with low dose PGE1 (<15 ng/kg/ mm) may not require mechanical ventilation for safe transport.


Related Articles

  • An Unusual Case of Suspected Microvascular Angina in a Newborn. Cataldo, Stefania; Annoni, Giuseppe Alberto; Fiocchi, Stefano; Mauri, Luigi Daniele; Corato, Alessandra; Vignati, Gabriele // Case Reports in Pediatrics;2012, p1 

    Myocardial ischemia in pediatric population is uncommon and usually due to congenital heart disease or extracardiac conditions leading to poor coronary perfusion. A 6-day-old newborn presented with respiratory distress and signs of heart failure. ECG, echocardiography, and laboratory results...

  • Primary Surgical Closure Should Be Considered in Premature Neonates with Large Patent Ductus Arteriosus. Seong-Min Ko; Young Chul Yoon; Kwang-Hyun Cho; Yang-Haeng Lee; Il-Yong Han; Kyung-Taek Park; Yoon Ho Hwang; Hee Jae Jun // Korean Journal of Thoracic & Cardiovascular Surgery;Jun2013, Vol. 46 Issue 3, p178 

    Background: Treatment for patent ductus arteriosus (PDA) in premature infants can consist of medical or surgical approaches. The appropriate therapeutic regimen remains contentious. This study evaluated the role of surgery in improving the survival of premature neonates weighing less than 1,500...

  • Newborn congenital heart defect screening burden low, requires consistency.  // Cardiology Today;Jun2013, Vol. 16 Issue 6, p23 

    The article discusses research being done on a statewide screening protocol for critical congenital heart defects in newborns initiated in New Jersey.

  • Enteral feeding in neonates with prostaglandin-dependent congenital cardiac disease: international survey on current trends and variations in practice. Howley, Lisa W.; Kaufman, Jon; Wymore, Erica; Thureen, Patti; Magouirk, Jeff K.; McNair, Bryan; da Cruz, Eduardo M. // Cardiology in the Young;Apr2012, Vol. 22 Issue 2, p121 

    BackgroundThe benefits of early enteral feeding in neonates are well known and yet the optimal pre-operative nutrition of prostaglandin-dependent infants with congenital cardiac disease remains ill-defined. This survey delineates international nutritional practices and trends with this...

  • Resolution of calcific brown fat necrosis associated with prostaglandin therapy for cyanotic congenital heart disease in neonates: report of two cases. Miller, Stephen; Miller, Stephen F // Pediatric Radiology;Nov2004, Vol. 34 Issue 11, p919 

    Prostaglandin E1 (PGE1) administration for palliation of cyanotic congenital heart disease in neonates has been associated with radiographically visible necrosis of brown fat about the neck and shoulder girdles. However, the natural history of this process has not been described. We present two...

  • The management of neonatal pulmonary hypertension. Dhillon, Rami // Archives of Disease in Childhood -- Fetal & Neonatal Edition;May2012, Vol. 97 Issue 3, pF223 

    Most neonates with clinically signifi cant pulmonary hypertension (PH) will have either persistent PH of the newborn (PPHN) or bronchopulmonary dysplasia. Cyanotic congenital heart disease must be actively ruled out as part of the differential diagnosis of PPHN. The maintenance of ductal patency...

  • Safety of cardiac magnetic resonance and contrast angiography for neonates and small infants: a 10-year single-institution experience. Rangamani, Sheela; Varghese, Joby; Li, Ling; Harvey, Lisa; Hammel, James; Fletcher, Scott; Duncan, Kim; Danford, David; Kutty, Shelby // Pediatric Radiology;Nov2012, Vol. 42 Issue 11, p1339 

    Background: With increasing applications of cardiac magnetic resonance (CMR) and magnetic resonance angiography (MRA) for evaluation of congenital heart disease (CHD), safety of this technology in the very young is of particular interest. Objective: We report our 10-year experience with CMR in...

  • Perinatal Management of Major Congenital Heart Disease. McGovern, Eimear; Sands, Andrew J. // Ulster Medical Journal;Sep2014, Vol. 83 Issue 3, p135 

    Congenital heart disease (CHD) is the most common form of congenital anomaly. Prenatal diagnosis of CHD has been associated with decreased morbidity and mortality for some forms of major CHD. As most cases of major CHD are not identified prenatally, clinical examination of the newborn and pulse...

  • Alprostadil.  // Reactions Weekly;1/9/2010 Part 1 of 2, Issue 1283, p10 

    The article describes the clinical cases of two female neonates who developed gastric outlet obstruction while under alprostadil (prostaglandin E1) for congenital heart disease. The first patient was diagnosed with tetralogy of Fallot with narrowing of the outflow from the right ventricle and...


Read the Article


Sign out of this library

Other Topics